Naloxone
Top View
- Pentazocine and Naloxone Tablets
- Use of Naloxone Opioid Antagonist by Non-Medical Staff Issue Date: 04/15/19 Supersedes: None – New Policy
- Asymptomatic Celiac Disease Leo Pruimboom1,2* and Karin De Punder1,3
- Opioid System Is Necessary but Not Sufficient for Antidepressive Actions of Ketamine in Rodents
- Talwin Nx (Pentazocine and Naloxone Hydrochlorides)
- Dezocine Alleviates Morphine-Induced Dependence in Rats
- Illinois Naloxone Standardized Procedure
- The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine Antagonist Therese A
- Embossable and Writable Multilaminate Backing
- Clinical Update
- Naloxone Brochure
- Electrophysiological Interactions of Isomers of Cyclazocine with the Phencyclidine Antagonist Metaphit in Rat Cerebellar Purkinje Neurons
- FDA Advisory Committee on the Most Appropriate Dose Or Doses of Naloxone to Reverse the Effects of Life-Threatening Opioid Overdose in the Community Settings
- United States Patent (19) 11 Patent Number: 5,866,164 Kuczynski Et Al
- Molecular Mechanisms by Which Salvinorin a Binds to and Activates the Kappa-Opioid Receptor
- Pharmacokinetics and Pharmacodynamics of Dextromethorphan: Clinical and Forensic Aspects
- MEDICATION GUIDE Pentazocine and Naloxone (Pen Tazʹ Oh Seen
- Ibogaine and Noribogaine: Comparing Parent Compound to Metabolite